
Lifestores Healthcare
Using technology to democratize access to quality and affordable primary healthcare in Africa.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
* | $50.0k | Grant | |
Total Funding | 000k |
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 8 % | 39 % | 21 % | 117 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Lifestores Healthcare was founded by Bryan Mezue and Andrew Garza with a mission to revolutionize the pharmacy landscape across Africa. The company aims to democratize access to quality and affordable primary healthcare by leveraging technology.
In October 2022, Lifestores Healthcare made headlines by raising $3 million in a seed funding round. This significant financial boost was led by investors such as Full Circle Africa and Aruwa Capital. The funding was pivotal in accelerating their growth and expanding their reach across the continent.
The founders, both with backgrounds in pharmaceutical sales and supply, identified a critical gap in the healthcare system—access to affordable medication. By integrating technology into the supply chain, Lifestores Healthcare has been able to streamline operations and reduce costs, making healthcare more accessible to underserved communities.
Lifestores Healthcare continues to grow, driven by its innovative approach and commitment to improving healthcare access. The company's journey reflects a broader trend of tech-driven solutions addressing fundamental challenges in emerging markets.